mild Severity

Ginkgo Allergy: Male Trees Cause Pollen, Female Trees Cause the Rash

Ginkgo biloba allergy presents 2 distinct reactions by tree sex: male trees produce wind-pollinated pollen (March–April) that can trigger mild IgE-mediated respiratory symptoms, while female trees produce seeds whose decaying sarcotesta releases ginkgolic acids — potent contact sensitizers structurally related to poison ivy's urushiol. Pollen allergy responds to seasonal antihistamines; contact allergy requires strict avoidance.

mildPeak: Mar–AprUpdated July 13, 2026

Free · 5 min · Insurance accepted

Reviewed by Dr. Chet Tharpe, M.D.
As seen inUSA TODAYMen's HealthCBSForbes
The numbers
Headline stat
<0%
US prevalence
Peak season
Mar–Apr
Symptoms tracked
0
Treatment paths
0
Peer-reviewed sources
0
  • Ginkgolic acids in female seed sarcotesta are anacardic acid derivatives sharing structural chemistry with urushiol from poison ivy — ivy-sensitized patients may develop cross-reactive contact dermatitis from ginkgo seeds.

    Lepoittevin et al., Arch Dermatol Res, 1989

  • EU standards require ginkgolic acid content below 5 ppm in dietary supplements to minimize contact sensitization risk from orally consumed Ginkgo biloba leaf extract.

    D'Amato et al., Allergy, 2007

  • 4-O-methylpyridoxine in ginkgo seeds can cause seizures and vomiting in children — a pharmacological toxicity entirely separate from the allergic ginkgolic acid mechanism.

    Rodríguez et al., Biomed Pharmacother, 2007

  • Ginkgo pollen grains are approximately 25–35 micrometers — large enough to settle rapidly near the source tree — limiting airborne dispersal and reducing the clinical significance of ginkgo as an aeroallergen.

    AAAAI, Tree Pollen Allergy Overview, 2024

01Overview

What Is Ginkgo Allergy?

Ginkgo biloba (Ginkgoaceae) is a living fossil — the sole surviving species of an ancient plant lineage — and it presents allergists with an unusual dual-mechanism clinical picture depending on whether exposure is to pollen from male trees or to the fruit sarcotesta of female trees.

Ginkgo is dioecious, meaning male and female reproductive structures are on entirely separate trees. Only male trees produce pollen; only female trees produce seeds enclosed in a fleshy outer coat (sarcotesta) that releases butyric acid and hexanoic acid upon decay — the infamous 'ginkgo smell' often compared to vomit or rancid butter. This biology creates two clinically distinct reactions.

First: pollen allergy from male trees, an IgE-mediated Type I hypersensitivity occurring during the March to April pollen season. Ginkgo pollen is a minor aeroallergen — some IgE reactivity has been documented in urban populations, but no WHO/IUIS allergens have been characterized, and population sensitization rates are low. Second: contact dermatitis from ginkgolic acids in the female fruit's sarcotesta — a potent Type IV delayed hypersensitivity caused by anacardic acid derivatives (15:1 and 17:1 ginkgolic acids) structurally related to urushiol from poison ivy.

Municipalities have historically planted only male trees to avoid the malodorous fruit — paradoxically increasing urban pollen load while eliminating the smell and fruit contact hazard.

02Symptoms

Symptoms of Ginkgo Allergy

Recognizing symptoms early helps you get the right treatment faster.

Seasonal rhinitis (pollen)

mild

Sneezing, runny nose, and nasal congestion occurring March through April from male ginkgo tree pollen inhalation.

Allergic conjunctivitis (pollen)

mild

Itchy, watery, and red eyes during ginkgo pollen season — typically mild compared to birch or grass pollen reactions.

Contact dermatitis rash (ginkgolic acids)

moderate

Papular and vesicular rash developing 24 to 48 hours after skin contact with female ginkgo seed sarcotesta; resembles poison ivy eruption.

Hand dermatitis

moderate

The most common site for ginkgolic acid contact dermatitis, occurring in those who handle fallen seeds or cook with ginkgo nuts.

Facial eczema from cross-contamination

moderate

Seeds touched and then hands contacting the face can transfer ginkgolic acid and produce perioral or eyelid dermatitis.

Throat irritation

mild

Mild throat pruritus or irritation may accompany seasonal pollen exposure in sensitized individuals during spring.

Ginkgo toxicity (non-immune)

severe

4-O-methylpyridoxine in ginkgo seeds can cause seizures and nausea in children — this is a pharmacological toxicity, not an allergic reaction. Seek emergency care immediately if seed ingestion is followed by neurological symptoms.

When to see a doctor

Ginkgo allergy symptoms depend on which exposure pathway is involved. Pollen-related symptoms (from male trees, spring) resemble mild seasonal allergic rhinitis: sneezing, itchy and watery eyes, nasal congestion, and mild throat irritation during March and April. Because ginkgo is a minor aeroallergen with low WHO/IUIS characterization, the severity of pollen symptoms is typically mild and may be overshadowed by concurrent birch or maple pollen exposure in the same season. Contact allergy symptoms (from ginkgolic acids in female tree sarcotesta) present as a poison-ivy-like eruption: papular and vesicular rash on the hands, arms, and any body area that touched the seed's fleshy coat, developing within 24 to 48 hours of contact and intensifying over 2 to 3 days. The distribution often involves the hands and face if seeds were handled and then the face was touched. Cross-reactive patients with poison ivy sensitization may experience a more severe and rapid response. Patients consuming ginkgo nuts in cooking should be aware that raw seed handling carries dermatitis risk. A board-certified allergist can help determine which mechanism — pollen IgE or ginkgolic acid contact — is responsible for your specific symptoms. Seek immediate medical care if a severe systemic reaction occurs after ginkgo ingestion.

Ginkgo Pollen and Asthma

Ginkgo pollen's role in asthma exacerbation is not well established due to the limited characterization of ginkgo pollen allergens and the minor-aeroallergen classification of the pollen itself. In patients with pre-existing pollen-triggered asthma, any exposure to co-occurring spring tree pollens (birch, maple) during March and April could exacerbate bronchial reactivity, and ginkgo pollen may contribute in areas of high male tree density. There are no published studies directly linking ginkgo pollen exposure to asthma hospitalization or exacerbation rates. Ginkgolic acid contact dermatitis, being a Type IV skin reaction, has no established bronchial component. Patients with asthma who take ginkgo biloba leaf supplements should discuss this with their physician, as supplements have been associated with rare platelet-altering effects that could interact with certain asthma medications.

If left untreated

Complications of Ginkgo Allergy

The most significant complication of ginkgo allergy relates to the contact dermatitis pathway rather than pollen exposure. Severe ginkgolic acid contact dermatitis — especially in patients cross-sensitized to poison ivy — can produce extensive vesicular eruptions requiring systemic corticosteroid treatment. Without prompt recognition and avoidance, repeated exposure during autumn leaf-fall season in cities with female trees can cause progressive sensitization. A specific risk exists with ginkgo supplement use: patients who develop ginkgolic acid sensitization from fruit contact may subsequently react to dietary supplements containing inadequately purified ginkgo extract, resulting in systemic dermatitis or mucosal reactions. Ginkgo seed toxicity is a non-immune complication particularly relevant for children: 4-O-methylpyridoxine in seeds can cause seizures and vomiting at doses of more than 5 seeds in children. This is a pharmacological, not allergic, emergency requiring immediate medical attention.

Severe vesicular contact dermatitis

Extensive blistering rash similar to severe poison ivy exposure can develop, particularly in patients cross-sensitized to urushiol.

Supplement cross-reactivity

Patients sensitized to ginkgolic acids via fruit contact may react to poorly standardized ginkgo biloba supplements containing elevated ginkgolic acid concentrations.

Secondary bacterial infection

Broken vesicular lesions from contact dermatitis can become colonized by Staphylococcus aureus, requiring antibiotic treatment.

Ginkgo seed neurotoxicity (children)

4-O-methylpyridoxine in raw seeds causes vomiting and seizures in children — a medical emergency requiring immediate evaluation, distinct from allergy.

03Why it happens

What Causes Ginkgo Allergy Reactions?

Two entirely separate exposure pathways cause ginkgo allergy. For pollen allergy, inhalation of windborne pollen from male ginkgo trees during March and April is the triggering event.

Common Species

Male ginkgo — produces pollen only; no fruit

Ginkgo biloba (male)

Female ginkgo — produces seeds with allergenic sarcotesta; no pollen

Ginkgo biloba (female)

Ginkgo pollen allergy operates through Type I IgE-mediated hypersensitivity: pollen proteins bind to IgE antibodies on mast cells in sensitized individuals, triggering histamine release and the classic allergic rhinitis cascade. Ginkgolic acid contact allergy operates through Type IV delayed hypersensitivity: anacardic acid derivatives form covalent bonds with epidermal proteins via electrophilic attack, creating hapten-protein conjugates that sensitize T lymphocytes. On re-exposure, activated memory T cells release cytokines causing inflammatory dermatitis at 24 to 96 hours. Cross-reactivity with urushiol (poison ivy) occurs because ginkgolic acids and urushiol share structural features — specifically long alkyl chain substitution on a phenolic ring — allowing sensitized T-cell clones to recognize both molecules.

Ginkgo is wind-pollinated, and in cities where municipal planting policies favor male trees, localized pollen concentrations can be moderate during the brief spring pollen window. Despite documented SPT positivity in some urban populations, ginkgo pollen has not yielded characterized WHO/IUIS allergen proteins, placing it in the minor-aeroallergen category with sparse clinical data.

For ginkgolic acid contact allergy, direct skin contact with the sarcotesta of female tree seeds — the fleshy yellow-orange outer coating — is the mechanism. The ginkgolic acids (anacardic acid class, 15-carbon and 17-carbon chain variants) are among the most potent plant contact sensitizers known, and they share structural chemistry with urushiol from poison ivy and Toxicodendron oak.

Patients sensitized to poison ivy may show cross-reactivity to ginkgolic acids. Additional exposure routes include roasting ginkgo nuts for culinary use (the high-temperature process reduces but does not eliminate ginkgolic acid risk during handling), and consumption of ginkgo biloba leaf extract supplements — EU regulations require ginkgolic acid content below 5 ppm in supplements to minimize sensitization risk.

Who's most affected

Risk factors to watch for

01

Proximity to female ginkgo trees

Handling or walking near fallen female ginkgo seeds in autumn significantly increases ginkgolic acid skin exposure and risk of contact sensitization.

02

Poison ivy cross-sensitization

Patients already sensitized to poison ivy urushiol carry cross-reactive T-cell memory that may recognize ginkgolic acids, producing contact dermatitis on first ginkgo seed contact.

03

Urban tree proximity (male trees)

In cities where municipal planting policies favor male trees, localized spring pollen concentrations can trigger mild respiratory symptoms in atopic individuals.

04

Ginkgo supplement use

Dietary supplements containing ginkgo biloba leaf extract may expose consumers to trace ginkgolic acids; EU standards require <5 ppm, but product quality varies internationally.

05

Culinary exposure (ginkgo nut roasting)

Handling raw ginkgo nuts during cooking — before sufficient heat has been applied — carries ginkgolic acid contact risk, particularly in Asian culinary traditions where ginkgo seeds are a common ingredient.

The Allergy Cascade

1.Exposure

Allergen contact

2.Detection

Immune recognition

3.IgE Response

Antibody production

4.Mast Cells

Histamine release

5.Symptoms

Allergic reaction

05Diagnosis

How Is Ginkgo Allergy Diagnosed?

Diagnosing ginkgo allergy requires distinguishing between the pollen IgE mechanism and the ginkgolic acid contact mechanism, as testing approaches differ substantially. For pollen allergy, skin prick testing with ginkgo pollen extract may be performed; some SPT positivity has been documented in urban populations, but because no characterized allergen proteins are commercially standardized, extract quality varies. Specific IgE blood testing for ginkgo pollen is available through some laboratory panels. For ginkgolic acid contact allergy, patch testing is the definitive diagnostic tool. The patch test typically uses ginkgo leaf or fruit extract applied under an occlusive patch for 48 hours, with readings at 48 and 96 hours. Ginkgo is not part of the standard North American patch test series, so it requires supplemental testing with plant material or commercially prepared extract. A thorough exposure history — covering proximity to female ginkgo trees, ginkgo supplement use, and culinary ginkgo nut handling — is essential before testing. For patients who also want to evaluate IgE-mediated spring tree pollen sensitization beyond ginkgo, at-home allergy testing services such as Curex offer an alternative to in-clinic testing, with panels covering 40+ common allergens including tree pollens and results typically within 5 days — often with insurance coverage.

Skin Prick Test (Pollen)

A lancet introduces a small amount of ginkgo pollen extract into the superficial skin, and wheal formation is read at 15 minutes. Detects IgE-mediated pollen sensitization.

Specific IgE Blood Test

A blood sample is tested for IgE antibodies specific to ginkgo pollen. Detects sensitization without skin exposure and is useful for patients who cannot undergo skin testing.

Patch Testing (Ginkgolic Acids)

Ginkgo leaf or fruit extract is applied under an occlusive patch for 48 hours to detect Type IV delayed contact hypersensitivity to ginkgolic acids. Readings at 48 and 96 hours.

At-home testing

Test from home with Curex

Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.

Take the allergy quiz
Insurance acceptedBoard-certified allergists
06Treatment

Treatment Options for Ginkgo Allergy

See how different approaches stack up for managing your allergy symptoms long-term.

Treatment strategies differ completely based on whether pollen IgE allergy or ginkgolic acid contact allergy is the primary mechanism. For pollen allergy during March to April, the treatment approach parallels other minor spring tree pollen allergies: allergen avoidance when pollen counts are high, pharmacologic symptom control, and consideration of immunotherapy if symptoms are sufficiently disabling. For ginkgolic acid contact allergy, strict avoidance of female tree seeds, careful handling of ginkgo nuts during cooking, and scrutiny of ginkgo biloba supplement ingredients are the foundational measures, combined with topical anti-inflammatory therapy for active dermatitis. Patients with confirmed poison ivy cross-sensitization to ginkgolic acids should treat female ginkgo seed contact with the same seriousness as poison ivy exposure — prompt washing of skin with soap and water within 10 minutes can reduce the amount of contact sensitizer absorbed.

Pollen Avoidance Measures

During March to April ginkgo pollen season, monitoring local pollen counts, keeping windows closed, and changing clothes after outdoor activity can reduce pollen load.

No medication — behavioral measures

Evidence for pollen avoidance in reducing rhinitis symptoms is consistent across allergen types; estimated 20–40% symptom reduction with diligent avoidance

Oral Antihistamines

Second-generation antihistamines taken during ginkgo pollen season control rhinitis and conjunctivitis symptoms without significant sedation.

Cetirizine (Zyrtec), fexofenadine (Allegra), loratadine (Claritin)

Clinical trials demonstrate 40–60% symptom reduction in seasonal allergic rhinitis with regular antihistamine use

Intranasal Corticosteroid Sprays

Nasal corticosteroid sprays are the most effective single-agent treatment for seasonal allergic rhinitis, reducing both nasal congestion and eye symptoms when used consistently.

Fluticasone (Flonase), mometasone (Nasonex), triamcinolone (Nasacort)

Meta-analyses show 30–50% reduction in total nasal symptom scores versus placebo; most effective when started 1 to 2 weeks before pollen season begins

Ginkgolic Acid Avoidance

For contact allergy: avoid touching fallen female ginkgo seeds, wear gloves when handling ginkgo nuts for cooking, wash hands and arms immediately after any exposure. Verify that ginkgo supplements meet EU standards for ginkgolic acid content (< 5 ppm).

No medication — behavioral and product measures

Complete avoidance eliminates contact dermatitis recurrence; the contact allergy mechanism has no pharmacological tolerance induction option

Topical Corticosteroids (Contact Dermatitis)

For active ginkgolic acid contact dermatitis, topical corticosteroids reduce inflammation and speed resolution of vesicular and papular rash.

Triamcinolone 0.1%, betamethasone dipropionate 0.05%, clobetasol 0.05% (prescription, for severe cases)

Clinical guidelines support topical corticosteroids as first-line therapy for contact dermatitis; significant improvement typically within 5 to 7 days

Sublingual or Subcutaneous Immunotherapy

For patients with documented IgE sensitization to ginkgo pollen with significant seasonal symptoms, allergen immunotherapy targeting the broader spring tree pollen spectrum may be considered. Ginkgo-specific extracts are not standardized commercially; treatment would address cross-reactive tree pollen components.

Tree pollen allergen extract (birch, oak, maple panel)

Clinical trials show 60–85% reduction in spring tree pollen rhinitis with sustained immunotherapy over 3 to 5 years

Traditional

  • NoTreats root cause
  • NoLong-lasting relief
  • YesAt-home treatment
  • YesNo office visits
  • YesLow side effects
  • PartialEstimated cost

Allergy Shots (SCIT)

  • YesTreats root cause
  • YesLong-lasting relief
  • NoAt-home treatment
  • NoNo office visits
  • PartialLow side effects
  • PartialEstimated cost

Immunotherapy (SLIT)

Recommended
  • YesTreats root cause
  • YesLong-lasting relief
  • YesAt-home treatment
  • YesNo office visits
  • YesLow side effects
  • YesEstimated cost
Immunotherapy

Immunotherapy for Ginkgo Pollen Allergy

Instead of masking symptoms, immunotherapy retrains your immune system.

Patients who test positive for IgE-mediated ginkgo pollen allergy and experience disabling spring symptoms may be candidates for immunotherapy — specifically targeting the broader spring tree pollen spectrum of which ginkgo is a part. Because ginkgo pollen allergens have not been formally characterized or standardized commercially, immunotherapy extracts would focus on cross-reactive spring tree pollen proteins rather than a ginkgo-specific formulation. The spring pollen season (March to April) when ginkgo releases pollen overlaps with birch, maple, and alder seasons — meaning a patient sensitized to ginkgo pollen is likely co-sensitized to other spring tree pollens, and a multi-allergen tree pollen immunotherapy program addresses the full seasonal burden. Subcutaneous immunotherapy (allergy shots) requires weekly clinic visits for the buildup phase, which some patients find difficult to maintain. Sublingual immunotherapy drops, offered by providers like Curex with plan-specific pricing (https://getcurex.com/learn/curex-pricing), can be taken at home, eliminating the need for weekly office visits while providing clinically documented desensitization for spring tree pollen sensitization. In a real-world, peer-reviewed Curex study of 2,897 patients on at-home sublingual immunotherapy (Tharpe et al., Frontiers in Allergy, 2026), clinically meaningful symptom improvement rose to 45% of patients by two years and quality-of-life improvement reached 90.7%, with adherence above 90%. It is important to note that immunotherapy addresses only the IgE-mediated pollen pathway — the ginkgolic acid contact allergy from female tree fruit is a Type IV T-cell-mediated mechanism that is not amenable to IgE immunotherapy. Avoidance remains the only management strategy for the contact component.

1Step 1

Allergy Testing

Skin prick or specific IgE blood testing confirms spring tree pollen sensitization including any ginkgo pollen component.

2Step 2

Determine Mechanism

Establish whether your symptoms are from pollen IgE (spring respiratory) or ginkgolic acid contact (autumn skin) — they require different management.

3Step 3

Begin Immunotherapy (if indicated)

For IgE-confirmed spring tree pollen allergy, start sublingual drops or allergy shots targeting the full spring tree pollen panel.

4Step 4

Monitor and Adjust

Reassess symptoms each spring season; immunotherapy benefit accumulates progressively over 3 to 5 years of consistent treatment.

“Clinical trials of spring tree pollen SLIT/SCIT show 60–85% symptom reduction in the majority of treated patients over a full treatment course”

Curex drops

Treat your Ginkgo allergy at the source

See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.

  • MD-led
    Board-certified allergists
  • Plan-specific
    Pricing · Confirm your quote
  • 50K+
    Patients treated
  • HSA/FSA
    Eligible
Living with it

Living With Ginkgo Allergy

Living with ginkgo allergy involves navigating two separate allergen calendars: the spring pollen season from male trees (March to April) and the autumn seed-fall season from female trees (August to November in most US cities). Many people are surprised to learn that a single tree species causes such mechanistically different reactions at different times of year. The good news is that both pathways are manageable once identified. Most US city-planted ginkgo trees are male (planted specifically to avoid malodorous fruit), meaning autumn contact hazard is lower in urban areas — though not eliminated in cities with older mixed or female plantings. Identifying the ginkgo trees in your immediate environment — whether they produce seeds in autumn — can substantially clarify your personal risk. For supplement users, the key concern is ensuring adequate standardization of purchased ginkgo products to minimize hidden ginkgolic acid exposure year-round.

  • Know your local trees

    Identify whether ginkgo trees in your neighborhood, campus, or workplace are male (no fruit) or female (produce fleshy seeds in autumn). Female trees with visible seed fall represent your primary autumn contact hazard.

  • Spring pollen routine

    During the March to April window, take your antihistamine or nasal spray proactively rather than reactively. Starting intranasal corticosteroids one week before typical symptom onset can prevent the initial inflammatory response.

  • Inform your kitchen

    If ginkgo nuts appear in recipes you prepare or meals served at Asian restaurants, be aware of your personal sensitization level. Well-cooked seeds are lower risk; raw handling requires gloves if you have confirmed ginkgolic acid contact allergy.

Ginkgo Pollen Season and Year-Round Contact Risk

Ginkgo pollen season is brief: male trees release pollen from March through April in temperate US cities, overlapping with birch and maple pollen seasons. The spring pollen window lasts approximately 2 to 4 weeks, producing light to moderate airborne pollen concentrations in urban areas where male trees are densely planted. Because municipalities have historically preferred male trees to avoid malodorous fruit, some US cities have concentrated pollen sources. Ginkgo pollen grains are ellipsoidal and approximately 25 to 35 micrometers in size — small enough for airborne transport. Despite this, ginkgo remains a minor aeroallergen, and pollen counts from ginkgo rarely achieve the levels associated with major spring allergens like birch, oak, or grass. The contact allergy risk from ginkgolic acids in female tree fruit is a late-summer to autumn phenomenon — seeds mature and fall between August and November. Cities still maintaining female trees, or hybrid-planted streets where both sexes were inadvertently planted, may have autumn foot-traffic contact hazards from fallen seeds. Supplement-related ginkgolic acid exposure is year-round and independent of season.

Spring

March - April

low intensity

Fall

August - November

medium intensity

How to Prevent Ginkgo Reactions

Prevention strategies differ by mechanism. For spring pollen allergy, the standard respiratory pollen mitigation measures apply during March and April: monitoring pollen forecasts, wearing sunglasses outdoors, showering after outdoor activity to wash off pollen, keeping windows closed on high-pollen days, and using HEPA air filtration indoors. For ginkgolic acid contact allergy, the most important prevention steps target the autumn seed-fall period: wear gloves when walking near female ginkgo trees with fallen seeds, do not allow children to handle the seeds, and wash hands thoroughly after any contact. In culinary contexts, gloves should be used when handling raw ginkgo nuts before sufficient heat application during cooking. Patients taking ginkgo biloba supplements should verify that products specify ginkgolic acid content below 5 ppm per EU standards.

Track spring pollen counts

During March and April, check local pollen forecasts and reduce outdoor activity on high tree pollen count days to minimize ginkgo pollen inhalation.

Wear gloves near female trees

In autumn when ginkgo seeds fall and decay, wear disposable gloves when walking through areas with female ginkgo trees, especially if picking up or handling seeds.

Immediate skin washing

If skin contacts ginkgo seed sarcotesta, wash the exposed area with soap and water within 10 minutes to reduce ginkgolic acid absorption before sensitization occurs.

Verify supplement purity

If taking ginkgo biloba supplements, choose products specifying ginkgolic acid content below 5 ppm — the standard used in the EU — to minimize contact sensitization risk from ingested extracts.

Identify tree sex before handling

Learn to identify female trees (those producing nuts or seeds in autumn) in your neighborhood or workplace vicinity so you can be alert during seed-fall season.

Long-term outlook

Prognosis for Ginkgo Allergy

The prognosis for ginkgo allergy depends on which mechanism is responsible for symptoms. Pollen allergy (spring, IgE-mediated) is a manageable chronic condition: symptoms can be well controlled with antihistamines and nasal sprays during the brief March to April season, and immunotherapy targeting the spring tree pollen panel can provide sustained long-term benefit. Because ginkgo is a minor aeroallergen with relatively short pollen season, pollen symptoms alone are typically less disabling than major allergen exposures. Ginkgolic acid contact allergy has an excellent prognosis with avoidance: once the female tree seed contact or supplement exposure is identified and eliminated, contact dermatitis resolves and does not recur as long as re-exposure is prevented. Contact sensitization persists immunologically — the memory T cells remain — so any future contact with ginkgolic acids will again trigger dermatitis. Patients who identify and address the correct mechanism early enjoy the best outcomes.

What to expect

Key takeaways

01

Ginkgo pollen allergy (spring) is mild and manageable with standard seasonal antihistamines and nasal sprays

02

Ginkgolic acid contact allergy (autumn) resolves with avoidance and has an excellent prognosis once the exposure source is identified

03

Cross-sensitization with poison ivy urushiol means more severe contact reactions are possible in previously poison-ivy-sensitized patients

04

Ginkgo biloba supplements should be standardized to <5 ppm ginkgolic acid content for sensitized individuals

Diet

Ginkgo and Diet — The Nut Cooking Consideration

Ginkgo seeds (nuts) are used in Chinese, Japanese, and Korean cuisine, appearing in congee, stir-fries, and traditional preparations. Raw ginkgo nuts contain ginkgolic acids in significant concentrations — cooking at high temperatures reduces but does not completely eliminate these compounds during the roasting or boiling process. For patients sensitized to ginkgolic acids from skin contact, culinary exposure to inadequately cooked ginkgo nuts represents a potential risk for mucosal or systemic reactions. Traditional advice is to thoroughly cook ginkgo nuts and to limit consumption to a small number (typically no more than 10 per sitting) given the 4-O-methylpyridoxine content. Patients who have had skin reactions to female ginkgo seed sarcotesta should discuss with their allergist whether culinary ginkgo nut exposure is safe. There is no pollen-food syndrome (OAS) documented for ginkgo because the pollen allergens are not characterized and no Bet v 1 homolog or LTP has been identified in ginkgo pollen.

Foods to limit

  • Raw ginkgo nuts (seeds)

    Raw ginkgo seeds contain ginkgolic acids and 4-O-methylpyridoxine; handling or eating raw seeds carries contact sensitization and neurotoxicity risk, especially for children.

Ginkgo teaches an important lesson about sex-dependent allergen biology — the same species causes two mechanistically opposite allergy syndromes depending on which tree sex you're near. Male trees produce pollen that follows a standard IgE pathway; female trees produce seeds whose chemistry is essentially liquid poison ivy.

Board-certified allergist (clinical reviewer for this article)
FAQ

Frequently Asked Questions

Ginkgo trees can cause mild hay fever-like symptoms, but only from male trees and only during the brief March to April pollen season. Ginkgo is a minor aeroallergen — its pollen has not yielded WHO/IUIS-characterized allergen proteins, and population-level sensitization rates are much lower than those for major spring tree pollens like birch or oak. In cities where municipal planners have planted predominantly male trees to avoid the malodorous female fruit, pollen exposure is concentrated but still at minor-allergen levels. If you have spring tree pollen hay fever, ginkgo may be a contributing trigger, but it is rarely the sole cause.

This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.

Get started today

Ready to treat your Ginkgo allergies for good?

Get a personalized treatment plan from board-certified allergists, delivered to your door.

Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.

Compare Curex plan pricing
3-minute quizBoard-certified allergistsProgram-specific pricing · Confirm your written quote

Questions about Curex itself?

Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.

Find out what you're actually allergic to — and treat the cause

Take the free allergy quiz

Ready to treat your allergies at the source?

Take the free allergy quiz to find out if immunotherapy is right for you and get started with personalized treatment today.

Take Free Allergy Quiz